Herman Waldmann

Corporate Officer/Principal presso The Royal College of Physicians

Consumer Services

Miscellaneous

Commercial Services

Posizioni attive di Herman Waldmann

Società	Posizione	Inizio	Fine
The Royal College of Physicians	Corporate Officer/Principal	-	-
The Royal Society	Corporate Officer/Principal	-	-
Academy of Medical Sciences Academy of Medical Sciences Miscellaneous Commercial ServicesCommercial Services The Academy of Medical Sciences was founded in 1998 and provides biomedical and health research services. The non-profit company is based in London, UK.	Corporate Officer/Principal	01/01/1998	-
University of Oxford	Corporate Officer/Principal	-	-

Società	Posizione	Inizio	Fine
Tolerx, Inc. Tolerx, Inc. BiotechnologyHealth Technology Tolerx, Inc. operates as a biopharmaceutical company in the discovery and development of therapies for immune-mediated diseases. They are also engaged in preclinical development of monoclonal antibody product candidates that engage the body’s immune system and promote and enhance immune responses. The company was founded in 2000 and is based in Cambridge, MA.	Direttore/Membro del Consiglio	01/07/2000	19/12/2011
	Fondatore	01/07/2000	19/12/2011
University of Cambridge	Corporate Officer/Principal	-	-

University of Cambridge

Doctorate Degree

Distribuzione geografica

Regno Unito	6
Stati Uniti	2

Posizioni

Corporate Officer/Principal	5
Doctorate Degree	1
Director/Board Member	1

Settori

Posizioni ricoperte

Attive

Inattive

Società quotate in Borsa

Aziende private

Aziende private	3
The Royal Society	Miscellaneous
Academy of Medical Sciences Academy of Medical Sciences Miscellaneous Commercial ServicesCommercial Services The Academy of Medical Sciences was founded in 1998 and provides biomedical and health research services. The non-profit company is based in London, UK.	Commercial Services
Tolerx, Inc. Tolerx, Inc. BiotechnologyHealth Technology Tolerx, Inc. operates as a biopharmaceutical company in the discovery and development of therapies for immune-mediated diseases. They are also engaged in preclinical development of monoclonal antibody product candidates that engage the body’s immune system and promote and enhance immune responses. The company was founded in 2000 and is based in Cambridge, MA.	Health Technology